Filter by consultation end date
Showing 1 to 10 of 28
| Title | Consultation | Type | Consultation end date | Sort date |
|---|---|---|---|---|
| Total distal radio-ulnar joint replacement for symptomatic joint instability or arthritis | Interventional procedure consultation | Interventional procedures guidance | Type:23 August 2017 | 20170823 |
| Micro-invasive subconjunctival insertion of a transcleral gelatin stent for primary open-angle glaucoma | Interventional procedure consultation | Interventional procedures guidance | Type:23 August 2017 | 20170823 |
| Extracranial to intracranial bypass for intracranial atherosclerosis | Interventional procedure consultation | Interventional procedures guidance | Type:23 August 2017 | 20170823 |
| Hypoglossal nerve stimulation for moderate to severe obstructive sleep apnoea | Interventional procedure consultation | Interventional procedures guidance | Type:23 August 2017 | 20170823 |
| Atezolizumab for treating metastatic urothelial bladder cancer after platinum-based chemotherapy [ID939] | Appraisal consultation: 1 | Technology appraisal guidance | Type:23 August 2017 | 20170823 |
| Macular degeneration | Draft guidance consultation | NICE guideline | Type:24 August 2017 | 20170824 |
| Neuroendocrine tumours (metastatic, unresectable, progressive) - 177 Lu-dotatate [ID1224] | Appraisal consultation | Technology appraisal guidance | Type:24 August 2017 | 20170824 |
| Bipolar disorder: assessment and management | Surveillance consultation | NICE guideline | Type:24 August 2017 | 20170824 |
| Atezolizumab for treating non-small-cell lung cancer after platinum-based chemotherapy [ID970] | Appraisal consultation | Technology appraisal guidance | Type:24 August 2017 | 20170824 |
| Pembrolizumab for urothelial cancer [ID1019] | Appraisal consultation | Technology appraisal guidance | Type:24 August 2017 | 20170824 |